Plain-English translation of NCT06878534 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Thyroid Cancer research guide →Researchers are studying the genetic makeup of different types of thyroid cancer to find new markers that could help predict which cancers are more aggressive and harder to treat. By analyzing tissue and blood samples from thyroid cancer patients, scientists hope to discover patterns in genes and molecules that influence how the cancer behaves and responds to treatment.
Currently, doctors classify thyroid cancers mainly by how they look under a microscope, but this doesn't always predict which patients will do well and which will face serious complications. This study aims to find new genetic clues that could help doctors better understand cancer aggressiveness and identify patients at higher risk, potentially improving treatment decisions.
You likely qualify if…
You likely don't qualify if…
This is a retrospective study, meaning researchers will use tissue and blood samples that have already been collected and stored from your past medical care — you won't need to visit a clinic or provide new samples. Researchers will analyze these existing samples using advanced genetic sequencing techniques to look for molecular patterns linked to cancer aggressiveness. The study team may also review your medical records to compare your cancer characteristics with your genetic results.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
Italy
Collaborators
University Federico II of Naples, Department of Clinical and Surgical Medicine
Enrollment target
~80 participants
Started
March 2023
Primary completion
July 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Giovanni Smaldone, Master degree in biothecnology
IRCCS SYNLAB SDN
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.